Conferences and symposiums A new frontier in precision medicine: to predict and prevent late effects in Adolescents and Young Adults (AYAs) treated for cancer
Join leading researchers and clinicians as we explore innovative approaches that can improve long-term health and quality of life for AYA cancer survivors.
Registration
Keynote session 1 - The burden of cancer in AYAs
Welcome - Introduction
Kenny Rodriguez-Wallberg Professor of Reproductive Oncology, Head of the PredictAYA Consortium, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
The burden of cancer in AYAs in Europe
Analisa Trama, Italian Cancer Institute, Milan, Italy
Infertility after cancer - Current knowledge gaps in fertility impact of cancer treatments
Richard Anderson, University of Edinburgh, UK
The experience of cancer in AYA age. Patient perspective
Mila Ogalla Toledo, Youth Cancer Europe, Madrid, Spain
Coffee break
Keynote session 2 - Current status of research on late effects of cancer treatments in AYAs
Late effects - An overview
Kenny Rodriguez-Wallberg, Professor of Reproductive Oncology. Coordinator of the EU-funded PredictAYA Consortium (predictaya.eu)
Cardiac late effects in cancer survivors
John Södling, Dept of Cardiology, Linköping University, Sweden
Reproductive late effects in cancer survivors - Use of biomarkers to monitor ovarian toxicity in cancer trials
Richard Anderson, University of Edinburgh, UK
Neurocognitive late effects in cancer survivors - Timing and prevalence of neurocognitive late effects in AYAs treated for cancer
Klas Blomgren, Karolinska Institutet, Stockholm, Sweden
Epidemiology in research of late effects - Timing and prevalence of late effects in AYAs treated for cancer
Sandra Eloranta, Karolinska Institutet, Stockholm, Sweden
Lunch - Restaurant Nanna Svartz
Keynote session 3 - Fertility concerns and fertility preservation in AYAs diagnosed with cancer
Fertility preservation for AYAs with cancer
Molly Moravek, Director of the Oncofertility Consortium, USA.
Teenagers' experiences of fertility preservation
Gabriela Armuand, School of Health and Social Studies, Dalarna University, Sweden
The Swedish Fex-Can Study of young people experiencing cancer
Lena Wettergren, Professor in Care Science, Uppsala University, Sweden.
Monitoring late effects in the clinic and involving AYA patients in research
Jeanette Winterling, Karolinska University Hospital, Stockholm, Sweden
Coffee break
Keynote session 4 - Precision oncology and prediction of late effects by pharmacogenomics
Prediction models using pharmacogenomics for late effects in AYAs treated with chemotherapy
Henrik Green, Professor of Pharmacogenomics, Linköping University
Precision medicine - Current developments in cancer care
Richard Rosenquist Brandell